stockportfolio.pro
Collegium Pharmaceutical, Inc. Gross Profit 2013–2025
Collegium Pharmaceutical, Inc. (COLL) annual gross profit by fiscal year, computed from SEC filings. Compound growth +61.3%/yr over 12 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $463.26M | 59.3% | +22.8% |
| FY 2024 | $377.34M | 59.8% | +15.7% |
| FY 2023 | $326.17M | 57.5% | +55.7% |
| FY 2022 | $209.49M | 45.2% | +39.1% |
| FY 2021 | $150.62M | 54.4% | -16.2% |
| FY 2020 | $179.84M | 58.0% | +74.5% |
| FY 2019 | $103.04M | 34.7% | -10.2% |
| FY 2018 | $114.74M | 40.9% | +343.3% |
| FY 2017 | $25.88M | 90.9% | +1627.7% |
| FY 2016 | $1.50M | 87.6% | — |
| FY 2015 | — | — | — |
| FY 2014 | — | — | — |
| FY 2013 | — | — | — |
Source: Collegium Pharmaceutical, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Collegium Pharmaceutical, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCollegium Pharmaceutical, Inc. — frequently asked questions
What is Collegium Pharmaceutical, Inc.'s gross profit?
Collegium Pharmaceutical, Inc. (COLL) reported gross profit of $463.26M for fiscal year 2025, per its SEC filings.
How has Collegium Pharmaceutical, Inc.'s gross profit changed over time?
Between fiscal 2013 and 2025, COLL's gross profit grew at roughly 61.3% per year (compound annual rate), from $1.50M to $463.26M.
Where does this data come from?
Figures are computed from Collegium Pharmaceutical, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.